Related Experiment Video
Updated: Aug 9, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein
R E Herrera1, T P Mäkelä, R A Weinberg
1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.
Abstract:
Transforming growth factor beta (TGF beta) inhibits cell proliferation by inducing a G1 cell-cycle arrest. Cyclin/CDK complexes have been implicated in this arrest, because TGF beta treatment leads to inhibition of cyclin/CDK activity. We have investigated the role of the retinoblastoma protein (pRb) in TGF beta-induced growth arrest by using RB+/+ and RB-/- primary mouse embryo fibroblasts. In both of these cell types, TGF beta inhibits CDK4-associated kinase activity. However, whereas CDK2-associated kinase activity was completely inhibited by TGF beta in the wild-type cells, it was reduced only slightly in the RB mutant cells. In addition, at high-cell density the growth-inhibitory effects of TGF beta are no longer observed in the RB-/- cells; on the contrary, TGF beta treatment promotes the growth of these mutant fibroblasts. Thus, under certain cellular growth conditions, elimination of pRb transforms the growth-inhibitory effects of TGF beta into growth-stimulatory effects. These observations could help to explain why TGF beta is often found to enhance tumorigenicity in vivo and why inactivation of the RB gene leads to tumorigenesis.
Insights
Transforming growth factor beta (TGF-β) normally inhibits cell proliferation. However, the retinoblastoma protein (pRb) is crucial, as its absence can make TGF-β growth-stimulatory, impacting tumorigenesis.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor beta (TGF-β) is known to inhibit cell proliferation via G1 cell-cycle arrest.
- Cyclin-dependent kinase (CDK) complexes are implicated in this arrest, as TGF-β treatment reduces their activity.
Purpose of the Study:
- To investigate the role of the retinoblastoma protein (pRb) in TGF-β-induced growth arrest.
- To understand how pRb status influences cellular responses to TGF-β.
Main Methods:
- Utilized wild-type (RB+/+) and retinoblastoma protein-deficient (RB-/-) primary mouse embryo fibroblasts.
- Assessed CDK4 and CDK2-associated kinase activities following TGF-β treatment.
- Observed cell proliferation and growth responses at high cell density.
Main Results:
- TGF-β inhibited CDK4 kinase activity in both RB+/+ and RB-/- cells.
- TGF-β completely inhibited CDK2 kinase activity in RB+/+ cells but only slightly in RB-/- cells.
- RB-/- cells showed a loss of TGF-β-mediated growth inhibition at high cell density, with TGF-β promoting their growth.
Conclusions:
- The retinoblastoma protein (pRb) is essential for the G1 cell-cycle arrest induced by TGF-β.
- Elimination of pRb can convert TGF-β's growth-inhibitory effects into growth-stimulatory effects under specific conditions.
- These findings may explain TGF-β's role in enhancing tumorigenicity and the link between RB gene inactivation and tumorigenesis.
Related Concept Videos
Negative Regulator Molecules
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
TGF - β Signaling Pathway

